Deerfield Management Company, L.P. (Series C) United Therapeutics Corp Transaction History
Deerfield Management Company, L.P. (Series C)
- $4.35 Billion
- Q2 2025
A detailed history of Deerfield Management Company, L.P. (Series C) transactions in United Therapeutics Corp stock. As of the latest transaction made, Deerfield Management Company, L.P. (Series C) holds 540,626 shares of UTHR stock, worth $163 Million. This represents 3.57% of its overall portfolio holdings.
Number of Shares
540,626
Previous 275,226
96.43%
Holding current value
$163 Million
Previous $84.8 Million
83.1%
% of portfolio
3.57%
Previous 2.15%
Shares
2 transactions
Others Institutions Holding UTHR
# of Institutions
740Shares Held
44MCall Options Held
334KPut Options Held
314K-
Black Rock Inc. New York, NY5.47MShares$1.65 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.45MShares$1.34 Billion0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.37MShares$714 Million12.42% of portfolio
-
State Street Corp Boston, MA2.17MShares$653 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.12MShares$639 Million0.86% of portfolio
About UNITED THERAPEUTICS Corp
- Ticker UTHR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,516,300
- Market Cap $13.7B
- Description
- United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...